Four months after it launched a clinical trial accelerator, Fresenius‘s (NYSE:FMS) renal research arm Frenova disclosed the initial participants. Fourteen research centers around the U.S. will take part in the F1RST Up accelerator (Frenova Rapid Start Up). Frenova general manager said in prepared remarks that the participants include “some of the most productive clinical research […]
Fresenius
Fresenius, Smiths in the hunt for Pfizer’s $1.5B infusion pump biz
Germany’s Fresenius (NYSE:FMS) and Britain’s Smiths Group (LON:SMIN) have emerged as the final bidders for Pfizer‘s (NYSE:PFE) infusion pump business, inherited via the Big Pharma’s September 2015 purchase of Hospira for $15 billion. The winning bid is expected to be around $1.5 billion, according to Reuters. Private equity firm Pamplona Capital Management was also interested and reportedly made a […]
Fresenius rebrands dialysis division to Fresenius Kidney Care
Fresenius Medical Care (NYSE:FMS) said yesterday it rebranded its dialysis service division under the new name Fresenius Kidney Care. With the move, Waltham, Mass.-based said it launched a new website for the business which offers education on dialysis, treatment options and other tailored information for people in various stages of kidney disease, the company said. “We created this […]
CSI reups supply deal with Fresenius
Cardiovascular Systems (NSDQ:CSII) said last week it extended its supply deal with Fresenius (NYSE:FMS) for its ViperSlide lubricant, extending the agreement through April 4, 2021. The extension to the agreement also gives Cardiovascular Systems final purchase rights upon the termination of the agreement or if Fresenius stops production of ViperSlide. St. Paul, Minn.-based Cardiovascular Systems said the […]
Fresenius, plaintiffs ask for more time for $250m settlement in dialysate cases
Fresenius Medical Care (NYSE:FMS) and the plaintiffs in a spate of lawsuits brought over its GranuFlo and NaturaLyte dialysis drugs yesterday asked a federal judge in Massachusetts to stay the case so they can finalize their $250 million settlement deal. The deal, brokered with a committee of plaintiffs’ representatives, requires that 97% of all patients who brought lawsuits sign […]
Fresenius misses the mark with Q4, 2015 results
Fresenius Medical Care (NYSE:FMS) reported 4th-quarter and 2015 results today that missed the mark on Wall Street, sending share prices down. The German dialysis giant posted profits of $394 million, or $1.04 per share, on sales of $3.55 billion for the 3 months ended Dec. 31, 2015, for a bottom-line slide of -2.2% on sales growth […]
Fresenius to settle dialysate lawsuits for $250m
Fresenius Medical Care (NYSE:FMS) said yesterday that its North American subsidiary agreed in principle to a $250 settlement of the multi-district litigation brought over its GranuFlo and NaturaLyte dialysis drugs. The deal, brokered with a committee of plaintiffs’ representatives, requires that 97% of all patients who brought lawsuits sign on by July. If that bar is met, Fresenius Medical […]
Fresenius acquires Japan’s largest dialysis group
(Reuters) – German kidney dialysis provider Fresenius (NYSE:FMS) has acquired Japan’s largest dialysis group with about 6,000 patients, newspaper Frankfurter Allgemeine Zeitung reported on Monday, citing a presentation made by the company in January. The paper, which cited minutes taken by analysts of remarks by FMC Chief Executive Rice Powell at the JPMorgan Healthcare Conference in […]
Fresenius’ Frenova launches clinical trial accelerator
Dialysis giant Fresenius‘s (NYSE:FMS) renal research branch Frenova said today it launched a renal research accelerator, titled F1RST Up, through an alliance of physician investigators in the nephrology research field. The accelerator aims to boost study startup through the elimination of administrative and contracting burdens that plague clinical trials, and are often responsible for delays, the […]
Fresenius opens China design center
Fresenius (NYSE:FMS) said it opened a new China Design Center in Shanghai to develop products for the Chinese and AsiaPacific regions. The center will consolidate procurement, local global manufacturing, quality organization facilities and sales and marketing teams to develop and focus on the needs of patients in the region, the company said. “We decided to open […]
Spectral Medical inks distribution deal with Fresenius
Septic shock treatment developer Spectral Medical said today it inked a deal with Fresenius Medical Care to distribute its Endotoxin activity assay devices. Fresenius will be the non-exclusive distributor of the device in Germany, Denmark, Sweden, Finland, Norway, Poland, Hungary and the Czech Republic, the company said. “We are very pleased to have entered into […]